6. Singapore Lymphoma Study (SLS)

Clinical Research Networks in Singapore	Contacts
Our research group draws together a national and international team comprising of basic scientists and clinicians with expertise in molecular epidemiology, next-generation sequencing, molecular pathology, bioinformatics and clinical trials. Importantly, our research also complements a nationwide genomic profiling program POLARIS (Personalised OMIC Lattice for Advanced Research and Improving Stratification). Consistent with the mission of POLARIS, we aim to administer the right therapies to the right patients at the right time. Our goal is to establish collaborations and synergy across all levels in Singapore so as to maximize resources and to increase the likelihood of significant success in realizing Singapore’s goal as a biomedical hub. Our team’s overarching aim is to address pressing clinical challenges faced by clinicians worldwide in treating T- and NK/T-cell NHL through: Performing integrated genomic profiling to identify driving mutations/translocations, pathogens, and genetic susceptibility in T- and NK/T-cell NHL. Identifying novel diagnostic, prognostic and therapeutic targets of T- and NK/T-cell NHL through functional studies driven by genomic discoveries. Developing the basis for rational, targeted molecular therapy in T- and NK/T-cell NHL.	A/Prof Lim Soon Thye Email: dmolst@nccs.com.sg Phone: +65 6436 8000 Website: Work in progress

Clinical Research Networks in Singapore

Contacts

Our research group draws together a national and international team comprising of basic scientists and clinicians with expertise in molecular epidemiology, next-generation sequencing, molecular pathology, bioinformatics and clinical trials. Importantly, our research also complements a nationwide genomic profiling program POLARIS (Personalised OMIC Lattice for Advanced Research and Improving Stratification). Consistent with the mission of POLARIS, we aim to administer the right therapies to the right patients at the right time. Our goal is to establish collaborations and synergy across all levels in Singapore so as to maximize resources and to increase the likelihood of significant success in realizing Singapore’s goal as a biomedical hub.

Our team’s overarching aim is to address pressing clinical challenges faced by clinicians worldwide in treating T- and NK/T-cell NHL through:

Performing integrated genomic profiling to identify driving mutations/translocations, pathogens, and genetic susceptibility in T- and NK/T-cell NHL.
Identifying novel diagnostic, prognostic and therapeutic targets of T- and NK/T-cell NHL through functional studies driven by genomic discoveries.
Developing the basis for rational, targeted molecular therapy in T- and NK/T-cell NHL.

A/Prof Lim Soon Thye
Email: dmolst@nccs.com.sg
Phone: +65 6436 8000
Website: Work in progress